4//SEC Filing
Rouan Sarah Kathryn 4
Accession 0001209191-24-001973
CIK 0001607678other
Filed
Jan 18, 7:00 PM ET
Accepted
Jan 19, 8:35 PM ET
Size
8.7 KB
Accession
0001209191-24-001973
Insider Transaction Report
Form 4
Rouan Sarah Kathryn
Director
Transactions
- Exercise/Conversion
Common Stock, par value $0.00001 per share
2024-01-19$8.32/sh+30,000$249,600→ 30,000 total - Sale
Common Stock, par value $0.00001 per share
2024-01-19$23.05/sh−30,000$691,500→ 0 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-01-19−30,000→ 25,000 totalExercise: $8.32From: 2020-07-01Exp: 2029-07-01→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 3, 2023.
Documents
Issuer
Viking Therapeutics, Inc.
CIK 0001607678
Entity typeother
Related Parties
1- filerCIK 0001761366
Filing Metadata
- Form type
- 4
- Filed
- Jan 18, 7:00 PM ET
- Accepted
- Jan 19, 8:35 PM ET
- Size
- 8.7 KB